Popular Articles

Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (Mesalamine) Delayed-Release Tablets For Moderately Active Ulcerative Colitis
Procter & Gamble Pharmaceuticals (P&GP) announced the availability of Asacol HD (mesalamine) delayed-release tablets, which are indicated for the treatment of moderately active ulcerative colitis (UC), a form of inflammatory bowel disease. UC involves inflammation of the lining of the colon and rectum and is typically characterized by flares followed by periods of remission. Moderately active UC is characterized by tougher symptoms than mildly active UC. Asacol HD is proven to help treat these tougher flares of moderately active UC. Asacol HD was approved by the U.S. Food and Drug Administration (FDA) based on evaluations from the ASCEND studies [Assessing the Safety and Clinical Efficacy of a New Dose of 5-ASA (4.8 g/day 800 mg tablet)].
buy viagra
Sanofi Pasteur Responds To Nation's Need For Hib Vaccine With Increased Supply
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced that the company has been able to increase the supply of its Hib-containing vaccines to enable the return to a full series of vaccinations for U.S. children. Based on the increased supply, on July 1, the U.S. Centers for Disease Control and Prevention (CDC) will reinstate its recommendation that children receive a booster dose of Haemophilus influenzae type b (Hib) vaccine after 12 months of age. The CDC also provided guidance on a phased approach to immunize children whose booster dose was previously deferred at their next regularly scheduled medical visit. The CDC had recommended a temporary deferral of the booster dose of Hib vaccine in 2007 due to supply constraints caused by another manufacturer"s withdrawal of Hib vaccine from the market. Since that time, Sanofi Pasteur has been, and continues to be, the sole supplier of Hib vaccine to the U.S. market.
News of the day
European CHMP Adopts Positive Opinion For Aztreonam Lysine
Gilead Sciences, Inc. (Nasdaq:GILD) announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency, has adopted a positive opinion on the company"s Marketing Authorisation Application for aztreonam lysine 75 mg powder and solvent for nebuliser solution (aztreonam lysine) for the suppressive therapy of chronic pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis (CF) aged 18 years and older. The opinion is for conditional approval, contingent on the successful completion of an ongoing study.
Diagnostics

U.N. Allocates $6M Emergency Fund To Address Health Problems In Ethiopia

The U.N."s Central Emergency Response Fund (CERF) recently allocated $6 million to address several health challenges facing Ethiopia, IRIN reports. Fidele Sarassoro, the U.N. humanitarian coordinator, said the country is having difficulty meeting the population"s basic health needs. The federal Disaster Risk Management and Food Security Sector (DRMFSS) has announced that rising malnutrition and food insecurity are a "growing concern and likely to lead to 6.2 million Ethiopians relying on food aid, out of a population of approximately 77 million," IRIN writes, adding that currently 4.9 million people in the country receive food aid (7/27). "The so-called belg rains, which normally fall between mid-February and mid-May, performed poorly, leaving many vulnerable families in an even more difficult position. Increasing admissions to therapeutic feeding programmes have also been recorded in several regions," according to a U.N. CERF release (7/23). According to the DRMFSS, the country has a shortfall of 176,000 tons of food, which is likely to increase to 390,000 tons by December 2009. CERF funding will focus on addressing malnutrition, food security problems and acute watery diarrhoea (AWD) outbreaks (7/27). In related news, the World Food Programme (WFP) recently said it will require a total of 744,000 metric tons of food to meet its commitments in Ethiopia this year, Ezega.com reports. Mohammed Diab, the WFP country director, said, "all of our programmes in this country [Ethiopia] are under stress right now, with the total shortfall currently standing at more than 199,000 metric tons of food, worth $171 million" (7/25). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):